Home › Funds › Telos Capital Management, Inc. › JNJ

Telos Capital Management, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Telos Capital Management, Inc. reported holding 45,050 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$11.9M, representing 1.05% of its reported portfolio and ranking #33 among its reported holdings. Telos Capital Management, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)45.05K sh
Reported value held$11.93M
Portfolio Weight1.05%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Telos Capital Management, Inc.'s JNJ position evolved

Telos Capital Management, Inc. first disclosed a stake in JNJ in Q3 2023 at 75,425 shares (US$11.7M). The position peaked in Q3 2026 at 45,050 shares, worth US$11.9M. Across 13 filings, Telos Capital Management, Inc. increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 45,050 shares valued at US$11.9M — a reduction of -999 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 75.42K $11.75M New
Q4 2023 73.32K $11.49M Reduce
Q1 2024 69.54K $11.00M Reduce
Q2 2024 55.31K $8.08M Reduce
Q3 2024 53.59K $8.69M Reduce
Q4 2024 54.30K $7.85M Add
Q1 2025 48.46K $8.04M Reduce
Q2 2025 48.93K $7.47M Add
Q3 2025 49.13K $9.11M Hold
Q4 2025 47.93K $9.92M Reduce
Q1 2026 46.47K $11.36M Reduce
Q2 2026 46.05K $11.69M Reduce
Q3 2026 45.05K $11.93M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Telos Capital Management, Inc. held JNJ?

Telos Capital Management, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Telos Capital Management, Inc.'s current position in JNJ?

As of Q3 2026, Telos Capital Management, Inc. holds 45.05K shares of JNJ (JOHNSON & JOHNSON), valued at $11.93M, representing 1.05% of its reported portfolio and ranking #33.

Has Telos Capital Management, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Telos Capital Management, Inc. reduced its position in JNJ. The position peaked in Q3 2026 at 45.05K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.